<qa>  What is the term for a preoperative Induction therapy?Patients with rectal adenocarcinoma of intermediate risk defined by magnetic resonance imaging MRI, without mutations in KRAS, BRAF, NRAS and PI3KCA, who are candidates for preoperative treatment, will receive a preoperative Induction therapy with 12 weeks of panitumumab with mFOLFOX-6 to evaluate the efficacy in terms of pathologic complete response pCR 